NCT03316144
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
- Locations
-
- Blood Diseases Hospital, Chinese Academy of Medical Sciences Tianjin, Tianjin Municipality, China
Clinical trial condition
Lymphoma
Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.
2,141 public trials
305 recruiting studies
Lymphoma trial results
NCT00536978
- Conditions
- Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +20 more
- Locations
-
- UT MD Anderson Cancer Center Houston, Texas, United States
Completed
Efficacy of the HCVIDDOXIL Regimen in Patients With Newly Diagnosed Peripheral T-Cell Lymphoma
NCT00290433
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
- Locations
-
- University of Texas MD Anderson Cancer Center Houston, Texas, United States
Completed
Phase II Study of Lenalidomide for the Treatment of Relapsed or Refractory Hodgkin's Lymphoma
NCT00478959
- Conditions
- Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +6 more
- Locations
-
Not specified
NCT00309842
- Conditions
- Acute Lymphocytic Leukemia, Acute Myeloid Leukemia, Anemia, +66 more
- Locations
-
- Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States
- Fred Hutchinson Cancer Research Center Seattle, Washington, United States
Completed
Evaluation, Treatment, and Natural History of Children and Young Adults With Cancer or Rare Diseases
NCT00001686
- Conditions
- Brain Diseases, Brain Neoplasms, Brain Tumors, +28 more
- Locations
-
- National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
NCT00534118
- Conditions
- Blood Protein Disorders, Bone Marrow Diseases, Burkitt Lymphoma, +58 more
- Locations
-
- Roswell Park Cancer Institute Buffalo, New York, United States
NCT01953783
- Conditions
- Advanced Solid Tumors, Hemic and Lymphatic Diseases, Immune System Diseases, +6 more
- Locations
-
- Cleveland, Ohio, United States
NCT02014129
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT-5 hours, EST), or speak with your personal physician. Tokyo, Japan
Completed
Polymorphisms at Distinct Genetic Loci Affect Response to Anti-CD20 Monoclonal Antibody Therapies
NCT02694913
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
- Locations
-
- Weill Medical College of Cornell University New York, United States